Identifying risk factors for recurrence/relapse in NF1 optic pathway gliomas: Moving forward by looking back

Neuro Oncol. 2022 Aug 1;24(8):1387-1388. doi: 10.1093/neuonc/noac081.

Authors

Anna F Piotrowski¹, Sadhana Jackson²

Affiliations

¹ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
² Surgical Neurology Branch, NINDS, and Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Intramural
Comment

MeSH terms

Brain Neoplasms*
Child
Humans
Neoplasm Recurrence, Local
Neurofibromatosis 1*
Optic Nerve Glioma* / metabolism
Optic Nerve Glioma* / therapy
Risk Factors

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States